Raghav "RV" Sehgal
@rv_sehgal
Followers
584
Following
605
Media
140
Statuses
469
š¬Solving Aging using AI, @Forbes 30u30 2025, Research Faculty @yale; Director at @H_L_Clinic; Created SymphonyAge @TruDiagnostic, Principal @LongevityTechFund
Yale Univeristy
Joined February 2021
It feels surreal, but here we are! Iām thrilled to share that Iāve been named to the @ForbesUnder30 list in the Healthcare category! @Forbes #ForbesUnder30
9
4
43
I was recently interviewed by @Forbes about the realities of being an immigrant in the United States, what it actually takes to build financial independence and wellness, and how one creates a sense of security in times that feel anything but stable. My journey from arriving as
1
1
2
Really excited for this event happening in NYC tonight! Thanks to Julie Vaughn from Longevity Global for organising this. Will be talking about our amazing work from @Yale on discovering aging biomarkers and longevity interventions using AI platforms! Come one, come all
luma.com
Join us for AI x Bio Night at IndieBio NYC on November 20th, 5:30ā8:00pm ā a gathering at the intersection of artificial intelligence and life sciences. Thisā¦
0
0
0
All my AI's are down!!! How am I going to build the next trillion dollar longevity company?š @Cloudflare @OpenAI @perplexity_ai @AnthropicAI
#Cloudflare #AI
0
0
1
National Institute on Aging (NIA) budget got cut in half for 2026! I saw a post by Andrew Steele talking about NIA's budget being cut in half and honestly I did not believe it. So I went to the NIA website myself to check the numbers ( https://t.co/IrTCf5Gnhe) and its absolutely
1
2
4
Thrilled to present at #GSA2025 this November! 𧬠āTranslAGE: A Unified Platform to Build and Translate Aging Biomarkers into Clinical Surrogate Endpoints.ā Join me at Hynes ā Room 306, Thu Nov 13, 10:00ā11:30 AM. Letās advance the future of translational #AgingResearch &
0
0
3
Honored to be representing Yale at the International Congress on Longevity in Bucharest this November. Iāll be speaking on āTranslating Geroscience to ClinicāĀ exploring how we move from biological aging theory to actionable tools that improve patient care. Itās inspiring to see
0
0
2
āYou donāt need any of this oxidized cholesterol in your body.ā Dr. Matthew OāConnor breaks down why 7-ketocholesterol ā an oxidized, toxic form of cholesterol ā is a major driver of vascular aging.
1
1
2
Presented our work on the bio vs tech reliability of clocks at @harvardmed's @agingbiomarkers. The key takeaway: both biological and technical factors shape how we interpret ābiological ageā ā and how confidently we can use it in clinical settings. Grateful to the organizers
0
2
7
I rarely post critical takes on othersā work, but this one was too frustrating to stay silent about. The idea of creating a quantifiable metric for scientific productivity is, in principle, a good one, especially if it helps weed out those who manipulate existing systems. But
Happy to see that our labās open-science tool, GScholarLens has been featured by @Nature. Dalmeet Chawla (@DalmeetS) does a fantastic job highlighting how GScholarLens brings transparency to scientific metrics, helping researchers, institutions, and the community better
1
0
1
TranslAGE is LIVE! We launched the first standardized platform for DNAm aging biomarker validation. We harmonized 179 datasets (>42K samples) to benchmark 41 clocks & 1,694 proxies using a new STAR framework. https://t.co/6MKfTxzpKc
#TranslAGE #Epigenetics
1
1
2
Ahead of Longevity Biotech 2025, I joined Monty Montano to discuss my path in aging research and how collaboration between academia & industry drives innovation. š„ Watch the full conversation here ā https://t.co/i9hmCYniDL Whatās your take ā where do you see the biggest
0
0
4
Honored to present at Longevity Biotech 2025 (Oct 22ā23, Boston). Thank you, Longevity Biotech, for the opportunity. My talk: āBiological vs. Technical Reliability of Epigenetic Clocks & Implications for Disease Prognosis & Intervention Response.ā Iāll discuss how to separate
0
0
5
Amazing work done by one of our close collaborators @david_van_dijk at @Yale! Upwards and onwards!
An exciting milestone for AI in science: Our C2S-Scale 27B foundation model, built with @Yale and based on Gemma, generated a novel hypothesis about cancer cellular behavior, which scientists experimentally validated in living cells.Ā With more preclinical and clinical tests,
0
0
4
𧬠Imagine your biological age changing overnight without you aging a day. Epigenetic clocks promise to quantify how fast weāre aging. But are their āticksā reliable? In our latest study using the TranslAGE platform built at @Yale , we systematically evaluated the technical and
1
2
3
@MaxUnfried Sure, if you can prove bias doesnāt impact how merit is evaluated. All the evidence points to the opposite.
0
1
4
Systems Age: a single blood methylation test to quantify aging heterogeneity across 11 physiological systems š āThis framework enables a more granular and clinically relevant assessment of biological aging and may support personalized approaches to monitor and target
nature.com
Nature Aging - Sehgal et al. report Systems Age as a framework to capture within-person heterogeneity in aging using a single blood-based epigenetic assay that measures aging across 11 body systems...
1
3
15
Itās finally out! My first, first author paper in @NatureAging! The first and only Epigenetic test to measure aging in 11 different organs of oneās body and which is currently on the market sold by @TruDiagnostic! A huge thanks to all the co-authors and my mentor
2
2
10